MaxCyte

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MaxCyte and other ETFs, options, and stocks.

About MXCT

MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing.

CEO

Douglas A. Doerfler

CEODouglas A. Doerfler

Employees

Employees84

Headquarters

Rockville, Maryland

HeadquartersRockville, Maryland

Founded

1998

Founded1998

Employees

Employees84

MXCT Key Statistics

Market cap

645.95M

Market cap645.95M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

922.48K

Average volume922.48K

High today

$6.41

High today$6.41

Low today

$5.77

Low today$5.77

Open price

$5.78

Open price$5.78

Volume

446.38K

Volume446.38K

52 Week high

$13.35

52 Week high$13.35

52 Week low

$3.36

52 Week low$3.36

Analyst ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

MXCT Earnings

-$0.08

-$0.05

-$0.03

$0.00

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 9, After Hours

ActualExpected Nov 9, After Hours

MaxCyte

Why Robinhood?

MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing. Show more

MXCT Key Statistics

Analyst ratings

100%

MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing.